Shruti Chandra

1.2k total citations
59 papers, 784 citations indexed

About

Shruti Chandra is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Shruti Chandra has authored 59 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Ophthalmology, 28 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Shruti Chandra's work include Retinal Diseases and Treatments (34 papers), Retinal Imaging and Analysis (26 papers) and Retinal and Optic Conditions (16 papers). Shruti Chandra is often cited by papers focused on Retinal Diseases and Treatments (34 papers), Retinal Imaging and Analysis (26 papers) and Retinal and Optic Conditions (16 papers). Shruti Chandra collaborates with scholars based in United Kingdom, India and United States. Shruti Chandra's co-authors include Sobha Sivaprasad, Jay Sheth, E. Michael Van Buskirk, Michael L. Klein, Eli A. Friedman, Andrew Lotery, Rebecca Kaye, Camiel J. F. Boon, Giridhar Anantharaman and Sarega Gurudas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The American Journal of Medicine.

In The Last Decade

Shruti Chandra

54 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shruti Chandra United Kingdom 13 626 470 103 52 47 59 784
Venediktos Kapetanakis United Kingdom 9 545 0.9× 386 0.8× 102 1.0× 25 0.5× 49 1.0× 20 705
Ferdinand Wit Netherlands 7 410 0.7× 280 0.6× 143 1.4× 50 1.0× 83 1.8× 11 640
Suganeswari Ganesan India 14 422 0.7× 300 0.6× 109 1.1× 34 0.7× 95 2.0× 33 584
Marc Baget‐Bernaldiz Spain 13 602 1.0× 517 1.1× 89 0.9× 9 0.2× 39 0.8× 36 744
Rukhsana G. Mirza United States 12 592 0.9× 472 1.0× 134 1.3× 7 0.1× 25 0.5× 49 726
Nichole Joachim Australia 15 661 1.1× 530 1.1× 119 1.2× 4 0.1× 55 1.2× 27 776
Raúl Navarro-Gil Spain 4 369 0.6× 312 0.7× 56 0.5× 7 0.1× 19 0.4× 8 440
Sarega Gurudas United Kingdom 10 345 0.6× 315 0.7× 76 0.7× 6 0.1× 34 0.7× 31 479
Kuan‐Yu Lin Taiwan 5 157 0.3× 109 0.2× 60 0.6× 24 0.5× 16 0.3× 14 299

Countries citing papers authored by Shruti Chandra

Since Specialization
Citations

This map shows the geographic impact of Shruti Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shruti Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shruti Chandra more than expected).

Fields of papers citing papers by Shruti Chandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shruti Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shruti Chandra. The network helps show where Shruti Chandra may publish in the future.

Co-authorship network of co-authors of Shruti Chandra

This figure shows the co-authorship network connecting the top 25 collaborators of Shruti Chandra. A scholar is included among the top collaborators of Shruti Chandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shruti Chandra. Shruti Chandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandra, Shruti, et al.. (2025). Gallbladder cholangiocyte organoids. Biology of the Cell. 117(2). e2400132–e2400132. 1 indexed citations
3.
Domalpally, Amitha, Shruti Chandra, Ioannis Dimopoulos, et al.. (2024). Photoreceptor assessment in age-related macular degeneration. Eye. 39(2). 284–295. 1 indexed citations
4.
Sivaprasad, Sobha, Shruti Chandra, Srinivas R. Sadda, et al.. (2024). Predict and Protect: Evaluating the Double-Layer Sign in Age-Related Macular Degeneration. Ophthalmology and Therapy. 13(10). 2511–2541. 4 indexed citations
5.
Chandra, Shruti, Sarega Gurudas, Ian Pearce, et al.. (2023). Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3. Eye. 38(7). 1301–1307. 2 indexed citations
6.
Chandra, Shruti, Sarega Gurudas, Ben Burton, et al.. (2023). Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2. Eye. 38(4). 757–765. 6 indexed citations
7.
Chandra, Shruti, Sarega Gurudas, Alan C. Bird, et al.. (2023). Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration. Biomedicines. 11(2). 560–560. 6 indexed citations
8.
Chandra, Shruti, et al.. (2023). Bacteriological profile and antibiotic susceptibility pattern of neonatal septicaemia-a prospective study. International Journal of Contemporary Pediatrics. 10(4). 506–509. 3 indexed citations
9.
Sivaprasad, Sobha, et al.. (2022). Perspectives from clinical trials: is geographic atrophy one disease?. Eye. 37(3). 402–407. 5 indexed citations
10.
Shah, Ami N., Cesar A. Santa‐Maria, Dhruvika Mukhija, et al.. (2022). A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases. Clinical Breast Cancer. 23(3). 324–329. 10 indexed citations
11.
Chandra, Shruti, Sobha Sivaprasad, Paul G. Ursell, et al.. (2021). Recurring themes during cataract assessment and surgery. Eye. 35(9). 2482–2498. 10 indexed citations
12.
Hagag, Ahmed M., et al.. (2020). One-year outcome of intravitreal Bevacizumab on eyes with choroidal neovascularization secondary to central serous chorioretinopathy. Investigative Ophthalmology & Visual Science. 61(7). 1072–1072.
13.
Hagag, Ahmed M., Shruti Chandra, Hagar Khalid, et al.. (2020). Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy. Journal of Clinical Medicine. 9(6). 1934–1934. 12 indexed citations
14.
Chandra, Shruti, Deepthy Menon, Namritha Patrao, et al.. (2020). Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration. Eye. 35(2). 409–417. 16 indexed citations
16.
Chandra, Shruti, Deepthy Menon, Hagar Khalid, et al.. (2020). Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration. Eye. 34(10). 1888–1896. 64 indexed citations
17.
Kaye, Rebecca, Shruti Chandra, Jay Sheth, et al.. (2020). Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Progress in Retinal and Eye Research. 79. 100865–100865. 154 indexed citations
18.
Chandra, Shruti, Declan Flanagan, Melanie Hingorani, Andrew Lotery, & Sobha Sivaprasad. (2020). COVID19 and ophthalmology: a brief summary of the literature. Eye. 34(7). 1200–1202. 6 indexed citations
19.
Chandra, Shruti, Jay Sheth, Giridhar Anantharaman, & Mahesh Gopalakrishnan. (2018). Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration. American Journal of Ophthalmology Case Reports. 9. 41–44. 25 indexed citations
20.
Sheth, Jay, Giridhar Anantharaman, Shruti Chandra, & Mahesh Gopalakrishnan. (2018). Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation. American Journal of Ophthalmology Case Reports. 9. 112–115. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026